Tuesday 1 June 2021

vaccine conjugates Market Key Companies Profile, Size and Share | Forecast to 2027

Regional Analysis

On the regional basis, the market is segmented into America, Europe, Asia Pacific and the Middle East & Africa. America dominates the largest market due to a significant use of the vaccine for preventing diseases and favorable conditions for research and development.

Europe is the second largest Conjugate Vaccines market in the globe followed by Asia Pacific. In Europe availability of funds for research and development activities and growing emphasis on research for prevention measures of diseases is increasing. Whereas, Asia Pacific shows the fastest growth in this market due to the increasing prevalence of communicable diseases. Developing countries in this region are emphasizing research on diseases caused to children’s and preventive measures for treating them. Mainly, India and China are expected to be an emerging and the fastest growing market due to the increasing population and prevalence of diseases.

The Middle East & Africa owns the lowest market in the global conjugate vaccines market due to less availability medical facilities.

Overview

Conjugate Vaccine are given to children to prevent transmission of diseases through infections and seasonal variation. Young children are more susceptible to infection that drives growth of the market. Moreover, increasing government support is expected to fuel the market’s growth during the forecast period. The International Vaccine Conjugates Market is expected to grow at a healthy CAGR of 14.5% during the forecast period 2018–2027.

Conjugate Vaccines are formed by covalently bonding a weak antigen to the strong antigen. This is done to boost the hosts’ immunological response. The poor antigen is a polysaccharide that is attached to the strong protein antigen. The major drivers for the growth of the global conjugate vaccine market are initiatives taken by the government, advancement in the vaccine formulation, and prevention of major infectious diseases, for instance meningitis and others.

An immature immune system can recognize these bacteria with the help of the conjugate vaccines, as these vaccines link the special polysaccharide coatings to an organism by producing immunity and response. The examples of conjugate vaccines are meningococcal vaccine to prevent meningitis, haemophilus influenzae type B (Hib) vaccine, and pneumococcal vaccine.

Browse Report Details at: https://www.marketresearchfuture.com/reports/vaccine-conjugates-market-1107

Key Players

Some of the key players in this market are GlaxoSmithKline plc. Merck & Co., Inc. (U.S), Fablife. (India), SutroVax Inc.(U.S), Sanofi Pasteur SA.(France), Pfizer (U.S), Sinovac Biotech Ltd. (China), IDT Biologics GmbH, GreenSignal Bio Pharma Limited (India), Taj Pharmaceuticals Limited (India), Bavarian Nordic(U.S).

Segments

The global Conjugate vaccine is segmented on the basis of type, indication, and end users. On the basis type it is segmented into Haemophilus B, monovalent, multivalent, others. On the basis of indication, it is segmented into Influenza, Pneumococcal, Meningococcal, others. On the basis of end users, it is segmented into pediatrics and adults.

Enema Bag Market Opportunities, Dynamics, Global Industry Analysis To 2027

 Regional Market Summary

Globally, the American region is the largest market for enema bags owing to the high level of hygiene developed in hospitals and clinics, increasing use of enema-based products at home, and rising demand for enema kits by healthcare providers. As per a study conducted by the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. Moreover, the study stated that 20% of the North American population suffers from constipation.

Asia Pacific and North America are expected to collectively dominate the enema bags market in terms of volume and value, respectively, due to the increase in awareness towards abdominal diseases and high demand from the pharmaceutical and healthcare industry. The U.S. has the largest market of enema bags in the North American region and countries such as India and China are the highest producers of enema bags in the Asia Pacific region. The factor influencing the growth is the increasing prevalence of chronic diseases such as obesity and diabetes. Currently, the major problem in China and India is diabetes. India had the world’s second-largest population of diabetic patients that was around 69.2 million in 2015 which is expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.

The European market is growing due to the increasing prevalence of diarrhea, obesity, and constipation. Increasing cases of enema administration procedures in hospitals are contributing to the progress of the market. The prevalence of diabetes is also found to be increasing in Europe. As per a study published by the World Health Organization, almost 60 million people in the European region have diabetes, and the prevalence tends to be high among people aging 30 years and above.

The Middle East and Africa also shows a steady rise in the market owing to the availability of enema-based products, lack of physical exercise, and increasing cases of constipation.

Get Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1363

Market Scenario:

Some health problems due to unhealthy eating, drinking in lifestyle may not be fatal but they can a hard time to the body they occur in. One such problem is constipation. A common remedy for constipation is an enema. Apart from constipation, enema provides relief from backaches, fatigue, and headaches. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly. A remedy helpful for many health problems always grows rapidly as a market.

The factors driving the market growth include rising chronic diseases in an aging population with cancer and diabetes coupled with the increasing prevalence of gastrointestinal disorders and growing awareness about enema administration. Home care is advisable to be administered only after the advice of the clinician. Factors that can cause roadblocks to the growth of global enema bags market include the possibility of newer methods of enema treatment and environmental concerns raised from the bags that are made up of silicone, rubber, etc.

Overview

Enema is the process of injecting fluid into the bowel via the rectum. This method is used to get relief from various conditions such as constipation, fatigue, headaches, and backaches. It is a process that helps to push out the waste from the rectum. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly.

The Global Enema Bags Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global enema bags market is expected to register a CAGR of ~ 10.2 % during the forecast period of 2018–2023.

Enema can be administered at hospitals as well as in home. This technique is also preferred before performing bowel procedures such as radiography and colonoscopy. The most common gastrointestinal condition affecting people nowadays is constipation with the ever-rising prevalence across the globe. Furthermore, the use of enema based products for bowel cleansing is growing extensively.

However, certain disrupting factors that might restrain the growth of enema bags include the possibility of newer methods of enema treatment. Moreover, there might be environmental issues as the bags are made up of silicone, rubber, etc.

Segmentation

The global enema bags market is segmented on the basis of the material type, product type, application, capacity, and end-user.

On the basis of material type, the market is classified into silicone, rubber, and others.

On the basis of administration type, the market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.

The global enema bags market on the basis of product type is segmented into closed or bottle enema, Higginson enema, bulb enema, bag or fountain travel enema, and others.

On the basis of indication, the market is segmented into constipation, diarrhea, obesity, cancer, and others.

On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas, and others. Barium enemas are further segmented into single-column barium enema and double-contrast barium enema.

On the basis of application, the market is segmented as bowel clearing, contrast x-ray, medication administration, and others.

On the basis of capacity, the market is segmented into 100 to 250 ml, 250 to 400 ml, 400 to 600 ml, and others.

On the basis of end-user, the global enema bags market is segmented into hospitals, clinics, research centers, and others.

Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American enema bags market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The European enema bags market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe.

The Asia Pacific enema bags market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.

The Middle Eastern and African enema bags market is segmented into the Middle East and Africa.

Top Key Players

The key players in global enema bags market are Baxter International, Inc. (the USA), B Braun Melsungen AG (Germany), Cascade Healthcare Products, Inc. (the USA), Coloplast A/S (Denmark), Covidien Private Ltd. (Ireland), Farla Medical Ltd. (UK), Flexicare Medical Limited (UK), Hollister Incorporated (USA), MacoPharma (France), Medline Industries, Inc. (USA), Narang Medical Ltd. (India), Ocean Health Products Ltd. (Singapore), and Qingdao Sinoland International Trade Co., Ltd. (China).

Browse Report Details at: https://www.marketresearchfuture.com/reports/enema-bag-market-1363

Browse Related Reports at:

Global Bariatric Surgery Market Size, Trends, Growth 2017-2027

Dietary Supplements in the Age of Personalized Nutrition Market Trends, Size, Share, Global Industry Forecast to 2027

Biomarker Technologies Market - Global Industry Size, Trends, Share and Forecast by 2027

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Hospital Furniture Market Profile, Trends and Applications Till 2027

 Hospital Furniture Market Competitive Analysis

Leading players in the global hospital furniture market include

  • Beaver Healthcare Equipment,
  • Moore Medical LLC,
  • Renray Healthcare Ltd.,
  • Bristol Maid Hospital Metalcraft,
  • DRE Inc.,
  • Anetic Aid Limited,
  • KI,
  • Bio Medical Solutions,
  • Narang Medical,
  • Hill-Rom,
  • Chang Gung Medical Technology,
  • GPC Medical Ltd.,
  • The Brewer Company,
  • Stryker Corporation

Get Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1007

In September 2019, a new super-specialty ward is expected to open in the Government Medical College and Hospital in Aurangabad, India. Redevelopment of existing medical facilities is likely to pick up speed in India in the coming years, making it a leading regional market for hospital furniture and driving the global hospital furniture market over the forecast period.

Hospital Furniture Market is expected to reach at 9.8% CAGR during forecast period from 2019 to 2023, by research report from Market Research Future (MRFR). The global hospital furniture market is mainly driven by the growing demand from emerging economies to develop their healthcare sector and the increasing investment in the healthcare sector by private entities, leading to a growing demand for premium, expensive hospital furniture offering the latest in ergonomics and comfort. Growing Demand in India, China to Drive Hospital Furniture Market.

Segments – Hospital Furniture Market

The global hospital furniture market is segmented on the basis of type into bedside tables, OT table, instrument stands, stretchers, hospital beds, chairs, scrub sinks, waste container, trolley and others.

On the basis of application, the global hospital furniture market is segmented into physician furniture, patient’s furniture, and staff’s furniture. Physician furniture is sub-segmented into examination table, surgery chair, and others. Patient furniture is sub-segmented into stretchers, bedside table, and other, while staff’s furniture is further segmented into stands and others.

On the basis of end users, the market is segmented into hospital, diagnostic centres, clinics and others. Hospitals hold the dominant share in the global hospital furniture market of 65% and are likely to remain the leading revenue generator in the global hospital furniture market over the forecast period.

Regional Analysis – Hospital Furniture Market

The Americas is likely to be the major revenue generator in the global hospital furniture market over the forecast period due to the growing demand for advanced hospital furniture in North America, especially the U.S. The growing presence of the private healthcare sector in North America is likely to be a major driver for the hospital furniture market in the Americas region over the forecast period. Private healthcare entities make more of an effort to pick the best furniture, to woo patients and new customers, whereas state-sponsored healthcare initiatives mainly pick hospital furniture based on utility rather than design or fashion. Thus, the strong presence of the private healthcare sector in North America is likely to be a major driver for the global hospital furniture market over the forecast period.

Europe is the second largest regional market for hospital furniture and is likely to hold on to a significant share in the global hospital furniture market over the forecast period. Europe is also home to several leading players in the healthcare sector, leading to a growing preference for expensive hospital furniture of a higher quality. The increasing efforts taken by the healthcare sector to engage and interact with patients in Europe are likely to be a key driver for the hospital furniture market in the region over the forecast period.

Browse Report Details at:: https://www.marketresearchfuture.com/reports/hospital-furniture-market-1007

Asia Pacific is the third largest regional market for hospital furniture, and is expected to exhibit the fastest growth over the forecast period due to the growing demand from the increasingly well-funded healthcare sector in the region. The healthcare sector in developing APAC economies such as India and China has exhibited robust progress in the last few years due to the increasing government support and the increasing investment from private sector individuals. This is likely to result in an increasing demand for hospital furniture in the region over the forecast period, as several new hospitals are likely to be constructed in this region over the forecast period, as well as renovation and redevelopment efforts bearing fruit.

Browse Related Reports at:

Alzheimer’s Disease Diagnostic Market by Type, Diagnostic test and Forecast to 2027

Population Health Management Market Size, Share, Growth, Industry Trends Analysis, Forecast 2027

Cosmetic Surgery Market Size, Growth and Share Analysis, 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Robotic Flight Simulator Surgery Market Key Players, Opportunities and Global Industry Analysis By 2027

 Global Industry Segmentations:

For ease of understanding, the market has been segmented into four key dynamics: –

The global robotic flight simulator surgery market is segmented on the basis of application, method, and end-user.

On the basis of application, the market is segmented into general surgery, cardiology surgery, neurosurgery, gynaecology, and others.

On the basis of method, the market is segmented into direct tele-manipulator and computer control.

On the basis of end-user, the market is segmented into hospitals, clinics, ambulatory surgical centres, and others.

Get Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/996

Many of the Market Vendors to improve their performance, and when it comes to expansion, they acquire promising companies in the rapidly growing markets. Technology providers, employing a continuous improvement strategy invest heavily to implement improvements and to develop new technologies to meet the consumers changing needs. Following are Some of the Key players leading the global robotic flight simulator surgery market include –

TransEnterix (U.S.)

Intuitive Surgical (U.S.)

Titan Medical (Canada)

AVRA (U.S.)

Virtualincision (U.S.)

Hansen Medical (U.S.)

Interventional Systems (U.S.)

Corindus Vascular Robots (U.S.)

Stryker (U.S.)

Mazor Robotics (Israel)

and among others

A robotic surgical system affords all the features that an experienced surgeon needs to ensure equivalent or superior outcomes to conventional surgery. However, Robot-assisted surgeries demand extensive training for surgeons to be able to operate with the help of a robotic assistant. Thus, training remains vital to develop some proficiency before surgeons start doing robotic surgeries on their own.

Overview

The global robotic flight simulator surgery market will gain significant accruals by 2023, registering a CAGR of 11.6% throughout the forecast period (2017 to 2023). Robotic flight simulator surgery, just like a flight simulator for pilots, offers training tools that can address the need for a realistic training environment for robot-assisted surgery.

Robot-assisted surgeries are trending everywhere wherein surgical robots are used to carry out various procedures. Surgeries performed with the help of surgical robots has many benefits such as reduced blood loss, reduced complications, reduced pain, and improved accuracy.

These simulators leverage the early learning curve of robot-assisted surgery that can shorten procedures without jeopardizing the safety and welfare of patients. Equipped with hi-tech solutions these simulators offer sufficient opportunities to surgeons that they have not had outside of the operating room.

Also, these surgeries require a shorter hospital stay which is not only good for the patients but also financially it’s good for a country’s health services. With the advancement of technologies, the prices of surgical robots are falling rapidly. Soon, each & every surgery will be performed using surgical robots.

LIST OF TABLES

Table 1 Global Robotic Flight Simulator Surgery Market Industry Synopsis, 2017–2023

Table 2 Global Robotic Flight Simulator Surgery Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Global Robotic Flight Simulator Surgery Market, by Region, 2017–2023, (USD Million)

Table 4 Global Robotic Flight Simulator Surgery Market, by Application, 2017–2023, (USD Million)

Table 5 Global Robotic Flight Simulator Surgery Market, by Method, 2017–2023, (USD Million)

Table 6 Global Robotic Flight Simulator Surgery Market, by End-User, 2017–2023, (USD Million

…To be Continued.

Browse Report Details at: https://www.marketresearchfuture.com/reports/robotic-flight-simulator-surgery-market-996

Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the rising prevalence of neurological diseases, presence of developed healthcare infrastructure, and high disposable income. Europe is anticipated to hold the second largest position in the global stereotactic surgery devices market. The market growth in this region is mainly due to the increasing occurrences of brain diseases and presence of developed healthcare sector. The Asia-Pacific region is expected to be fastest growing region owing to the growing prevalence of brain-related diseases and continuously growing healthcare sector. The Middle East & Africa has the least share of the market owing to the limited presence of developed healthcare infrastructure in the African region.

Browse Related Reports at:

Erectile Dysfunction Drugs Market Size Analysis, Trends , Share, Forecast to 2027

Transplant diagnostics Market Size, Industry Share Analysis, Technology Trends Forecast 2027

Monoclonal Antibody Therapy Market Size, Share & Trends – Forecast to 2027 

About Market Research Future: Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions

Monday 24 May 2021

Cancer Registry Software Market Key Companies Profile, Research and Insights | Forecast to 2027

 Cancer Registry Software Market Overview

Market Research Future (MRFR) announces the publication of its research report –Global Cancer Registry Software Market, 2019 to 2024. The global cancer registry software market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.

Nowadays, the prevalence of various types of cancer is found to be increasing across the world. According to the World Cancer Research Fund International, in 2015, cancer was responsible for 8.8 million deaths and is the second leading cause of death across the globe. Osteosarcoma is yet another kind, contributing to 36% of all types of bone cancer

Prevalence of cancer has increased to a great extent, mainly in children and teens. Thus, the increasing population of these patients has generated demand for better treatment, which helps them to get effective outcomes. Also increasing the footfall of patients who have cancer create the challenge for doctors in handling and providing a better treatment which leads the demands for better drugs in the coming future.

FREE SAMPLE COPY OF Cancer Registry Software Market Research Report- Global forecast till 2023” https://www.marketresearchfuture.com/sample_request/7852

Mergers, acquisitions, and collaborations have improved the research and development process owing to different technologies coming together to create potent treatment options. These strategies also help in the development of new drugs for better treatment, which also increases the global network of the players. Mergers and acquisitions help to enhance the revenue through a gain in market share and also generate tax gain. Many companies want to enter the new market, but due to lack of knowledge about the new market and less research and development activities, companies may face a challenge. Thus, the only strategy of these companies entering into the merger, acquisition, and collaboration to access the new market more effectively and profitably. This activity helps companies to minimize the cost of operation and production, gain higher competitiveness, financial leverage, in achieving administrative benefits and help in positioning the products.

On a regional basis, the global market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the region owing to the innovative product development and increasing investment in research and development for innovation in the region.

The global cancer registry software market has been segmented into type, deployment model, database type, functionality, and end user.

Cancer Registry Software Market outlook 2019 to 2024 is Published By Market Research Future. Accoding to MRFR Global Cancer Registry Software Market Report Analyzed By Type (Integrated Software, Standalone Software), Deployment Model (Cloud-Based, On-Premise), Database Type (Commercial, Public), Functionality (Patient Care Management, Product Outcome Evaluation, Cancer Reporting to Meet State, Federal Regulations, Medical Research and Clinical Studies), End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) – Global Industry Forecast till 2024

Global Cancer Registry Software Market, by Key Players

  • Onco, Inc.
  • Rocky Mountain Cancer Data Systems
  • McKesson Corporation
  • Elekta AB (PUB)
  • C/Net Solutions
  • Electronic Registry Systems, Inc.
  • ROCKY MOUNTAIN CANCER DATA SYSTEMS
  • MCKESSON CORPORATION
  • ORDINAL DATA, INC
  • CONDUENT, INC
  • IBM
  • HIMAGINE SOLUTIONS INC

Intended Audience

  • Software companies
  • Contract research organizations
  • Academic and research institutes
  • Government associations

Table Of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Pricing Analysis

Chapter 6. Global Cancer Registry Software Market, By Type Of Service

Browse Complete 90 Pages Premium Research Report Enabled with 110 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852

Browse More Related Reports at:

Menstrual Cup Market Size, Share, Trends, Industry Analysis and Forecast To 2027

Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR

Cell Therapy Market Growth, Size, Trends, Report Analysis, Forecast to 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Epilepsy Market Sales, Cost and Profit Till 2027

 Epilepsy Market Overview:

The epilepsy market is driven by the spurt witnessed in epilepsy cases. According to the World Health Organization (WHO) report on epilepsy in 2017, nearly 50 million were diagnosed with the disorder. The geriatric populace diagnosed with the same can significantly drive the market growth.

According to the Brain Injury Association of Michigan, brain injury is one of the main causes noticed in 40% cases of epilepsy. Rise in number of road accidents in developed economies can support the fact. Rise in partial epilepsy seizures resulting from brain injuries is another market driver. The spike in neurological disorders such as depression and Parkinson’s is predicted to fuel the epilepsy market growth. According to the National Center for Biotechnology Information, the number of cases of Alzheimer’s among the elderly in 2017 was recorded at 80% and it can increase exponentially.

The influx of capital by research institutes to expedite the development of drugs for the treatment of seizures caused by epilepsy is likely to bolster the market demand. According to the National Institute of Neurological Disorders and Stroke, nearly USD 152 million was dedicated to epilepsy research in 2019.

Avail Free Sample at https://www.marketresearchfuture.com/sample_request/7730

Epilepsy Market Regional Analysis:

Region-wise, the epilepsy market is segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). Among them, the Americas accounted for 41% share in 2017, followed by Europe, APAC, and MEA.

Europe is expected to exhibit 8.31% CAGR over the forecast period. Increased investment in research and development of effective drugs to treat epilepsy coupled with high incidence of the disorder are factors projected to drive regional market growth exponentially.

APAC epilepsy market is set to touch a valuation of USD 2,046.57 million by 2023 due to high incidence of the disorder registered in the region. In addition, countries of India, South Korea, and China emerging as viable destinations for testing and development of novel drugs can spur market demand over the forecast period.

Key players in the epilepsy market include,

  • Eisai Co. Ltd.
  • Novartis AG
  • Pfizer Inc.
  • GW Pharmaceuticals PLC
  • Abbott Laboratories
  • UCB SA
  • LivaNova PLC
  • Medtronic PLC
  • Johnson & Johnson Services Inc.
  • GlaxoSmithKline PLC
  • and NeuroPace Inc.

Epilepsy Market Segmentation Analysis:

The global epilepsy market is segmented By Condition, Diagnosis & Treatment, and End-User.

By condition, the ‘others’ segment accounted for 70.5% market share in 2017. It is touted to reach a worth close to USD 6,571.40 million by 2023. On the other hand, the drug resistant epilepsy segment is projected to reach a valuation of USD 2,937.80 million by the end of the forecast period. Emergence of rational polytherapy for treating the disorder with negligible side-effects is likely to accrue significant revenue for the epilepsy market.

By diagnosis & treatment, the treatment segment held 66.2% share of the epilepsy market in 2017. The segment can exhibit 7.91% CAGR during the forecast period due to availability of affordable drugs for treating partial epileptic seizures. In addition, approval of effective drugs by regulatory agencies can facilitate growth in the segment. It is expected to be worth USD 6,198.63 million by 2023. On the other hand, the diagnosis segment is predicted to enjoy 8.76% CAGR over the assessment period. Utilization of various imaging tests and blood tests for early discernment of the disorder is expected to drive the segment growth exponentially. For instance, CT scans are used for revealing abnormalities in the brain which can catch the probability of epilepsy at an early stage.

By end-user, hospitals were the largest segment of the market with a valuation of USD 1,739.22 million in 2017. It is projected to exhibit a stellar 8.29% CAGR over the forecast period. On the other hand, clinics can showcase higher CAGR of 8.93% during the assessment period owing to clinics being a preferred center for diagnosis and treatment. In addition, adoption of latest equipment by doctors to provide excellent patient care can spur the growth of the segment.

To Access Complete Premium Research Report at https://www.marketresearchfuture.com/reports/epilepsy-market-7730

Browse More Related Reports at:

Medical Marijuana Market Statistics | Global Industry Size, Growth, And Forecast To 2027

CAR T Cell Therapy Market Size, Share, & Trends Analysis | Forecast to 2027

Healthcare Artificial Intelligence (AI) Market Size, Global Report, Trends, Industry Analysis by 2027

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Opioids Market Profile, Opportunities and Global Industry Analysis To 2027

 Opioids Market Overview

Leading Market Players

Sanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.

Segmentation Analysis

The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

The global OPIOIDS MARKET is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.

PICK UP THE FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/7626

Table of Content

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Use Of Opioids For Disease Condition Causing Chronic Pains Such As Cancers, Arthritis, Lower Back Pain, And Fibromyalgia

4.2.2 Favorable Reimbursement Policies For Palliative Care In Developed Regions

4.2.3 Substantial Rise In Road Accidents, Trauma, And Surgical Procedures

4.3 Restraints

4.3.1 Rising Addiction And Death Cases Due To Overdose Of Opioid 26

4.4 Opportunities

4.4.1 Reconsideration Of Prescribing Opioid Analgesics Due To Rising Awareness About Opioids Misuse, Abuse, And Overdose Has Prompted Many Stakeholders

List of Tables

TABLE 1 MARKET SYNOPSIS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)

TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)

TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)

Continued…

COLLECT DETAILED INFORMATION OF THE REPORT @ https://www.marketresearchfuture.com/reports/opioids-market-7626

Intended Audience

  • Pharmaceutical Companies
  • Research Institutes
  • Hospitals
  • Academic Institutes

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market.

Browse More Related Reports at:

Negative Pressure Wound Therapy Market Share, Industry Trends and Forecast to 2027

Electric Wheelchair Market Growth Analysis, Size, Global Share and Industry Forecast to 2027

Blood Collection Market Research Report - Forecast to 2027 | MRFR

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...